Salk Institute

Thomas Lab

Molecular Neurobiology Laboratory

Glioblastomas, one of the most common types of brain tumors, are aggressive and incurable. Not only are the tumors hidden inside the skull, but they also contain many aberrant pathways acting as cohorts to drive the cancer’s growth. Turning off just one of these pathways with a drug might not stop the cancer. With a better understanding of how all these pathways activate each other—like falling dominoes—researchers may be able to figure out how to reverse the cancer once and for all.

John Thomas studies the molecules that help the brain grow in a developing embryo and which are later reactivated in many aggressive cancers of the nervous system. In both an embryo and a cancer, these molecules act in pathways that encourage the growth of brain cells; in the case of the embryo, that’s a good thing, while in cancer, it’s not. By studying both brain development and the molecular details of brain tumors, Thomas can determine where the two overlap—and where the pathways have weaknesses that will allow them to be turned off with drugs, stopping cancer growth.

Thomas developed a Drosophila (vinegar fly) model of brain tumors—using flies with particular genetic mutations allows him to probe the domino effect of these pathways as well as test potential treatments.

 

© 2017 Salk Institute for Biological Studies
10010 N Torrey Pines Rd, La Jolla, CA 92037 | 858.453.4100 | webmaster@salk.edu